Why Abiomed Stock Is Being Mauled Today

Investors in Abiomed (NASDAQ: ABMD), a medical device company focused on temporary heart pumps, are having a tough day. Shares were down about 26% at 12:36 p.m. EDT on Thursday after the company reported mixed quarterly results and lowered full-year guidance.

Here are the key takeaways from the first quarter of fiscal 2020:

Image source: Getty Images.

Continue reading

Quelle Fool.com